Immunophenotyping in the diagnosis of acute leukaemias. General Haematology Task Force of BCSH.
R. M. Rowan(St Bartholomew's Hospital), Michael J. Murphy(St Bartholomew's Hospital), James A. Bain(Royal Marsden NHS Foundation Trust), N. K. Shinton(St Bartholomew's Hospital), Julie England(St Bartholomew's Hospital), Estella Matutes(Institute of Cancer Research), Karen Hyde(Royal Marsden NHS Foundation Trust), Jason Wood(St Bartholomew's Hospital), Judith Reilly(Royal Marsden NHS Foundation Trust), Andrew Stephens(University of Michigan), S. Mitchell Lewis(St Bartholomew's Hospital)
Cited by 24
Related Papers
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
|The Lancet|2007|679
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma
|Blood|2018|112
Effectiveness of 0.08 molar iodine in ethanol solution as a means of chemical surface passivation for photoconductance decay measurements
|Solar Energy Materials and Solar Cells|1997|79
Machine learning-based cytokine microarray digital immunoassay analysis
|Biosensors and Bioelectronics|2021|56